Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Cobelli

Showing results (381-390 of 392) with videos related to

Pageof 40
Sort By:
Diabetes Technology & Therapeutics|December 17, 2016
Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin DeliveryBoris Kovatchev, Peiyao Cheng, Stacey M Anderson, et al.
Metabolism: Clinical and Experimental|May 14, 2016
Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trialAndrew L Siebel, Si Khiang Trinh, Melissa F Formosa, et al.
Diabetologia|May 30, 2014
Novel genetic susceptibility loci for diabetic end-stage renal disease identified through robust naive Bayes classificationFrancesco Sambo, Alberto Malovini, Niina Sandholm, et al.
Diabetes Technology & Therapeutics|July 9, 2014
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sitesHoward Zisser, Eric Renard, Boris Kovatchev, et al.
Diabetes Care|October 15, 2017
Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A<sub>1c</sub> and HypoglycemiaEyal Dassau, Jordan E Pinsker, Yogish C Kudva, et al.
Diabetes Care|May 22, 2016
Multinational Home Use of Closed-Loop Control Is Safe and EffectiveStacey M Anderson, Dan Raghinaru, Jordan E Pinsker, et al.
Diabetes Care|October 31, 2013
Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-managementYoeri M Luijf, J Hans DeVries, Koos Zwinderman, et al.
Diabetes Care|November 23, 2017
International Consensus on Use of Continuous Glucose MonitoringThomas Danne, Revital Nimri, Tadej Battelino, et al.
Diabetes Care|June 10, 2019
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in RangeTadej Battelino, Thomas Danne, Richard M Bergenstal, et al.
Journal of the American Society of Nephrology : JASN|September 21, 2016
The Genetic Landscape of Renal Complications in Type 1 DiabetesNiina Sandholm, Natalie Van Zuydam, Emma Ahlqvist, et al.
Pageof 40

Showing results (381-390 of 392) with videos related to

Sort By:
Pageof 40
Diabetes Technology & Therapeutics|December 17, 2016
Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin DeliveryBoris Kovatchev, Peiyao Cheng, Stacey M Anderson, et al.
Metabolism: Clinical and Experimental|May 14, 2016
Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trialAndrew L Siebel, Si Khiang Trinh, Melissa F Formosa, et al.
Diabetologia|May 30, 2014
Novel genetic susceptibility loci for diabetic end-stage renal disease identified through robust naive Bayes classificationFrancesco Sambo, Alberto Malovini, Niina Sandholm, et al.
Diabetes Technology & Therapeutics|July 9, 2014
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sitesHoward Zisser, Eric Renard, Boris Kovatchev, et al.
Diabetes Care|October 15, 2017
Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A<sub>1c</sub> and HypoglycemiaEyal Dassau, Jordan E Pinsker, Yogish C Kudva, et al.
Diabetes Care|May 22, 2016
Multinational Home Use of Closed-Loop Control Is Safe and EffectiveStacey M Anderson, Dan Raghinaru, Jordan E Pinsker, et al.
Diabetes Care|October 31, 2013
Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-managementYoeri M Luijf, J Hans DeVries, Koos Zwinderman, et al.
Diabetes Care|November 23, 2017
International Consensus on Use of Continuous Glucose MonitoringThomas Danne, Revital Nimri, Tadej Battelino, et al.
Diabetes Care|June 10, 2019
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in RangeTadej Battelino, Thomas Danne, Richard M Bergenstal, et al.
Journal of the American Society of Nephrology : JASN|September 21, 2016
The Genetic Landscape of Renal Complications in Type 1 DiabetesNiina Sandholm, Natalie Van Zuydam, Emma Ahlqvist, et al.
Pageof 40